- Previous Close
1.4800 - Open
1.4800 - Bid 1.4600 x --
- Ask 1.5000 x --
- Day's Range
1.4600 - 1.5150 - 52 Week Range
0.6800 - 4.9700 - Volume
38,185 - Avg. Volume
61,981 - Market Cap (intraday)
68.873M - Beta (5Y Monthly) 0.43
- PE Ratio (TTM)
6.95 - EPS (TTM)
0.2100 - Earnings Date --
- Forward Dividend & Yield 0.04 (2.74%)
- Ex-Dividend Date Nov 5, 2024
- 1y Target Est
5.15
EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally. The company operates through Brought in Lines and Company Owned Products segments. It is also involved in the wholesale distribution of the EAORON branded skin care products to retailers. In addition, the company engages in research, development, and sale of genomics. Further, it offers precision nutrition research products under the EZZ brand. EZZ Life Science Holdings Limited offers its products online. The company was incorporated in 2015 and is based in Lidcombe, Australia.
ezzlife.com.auRecent News: EZZ.AX
View MorePerformance Overview: EZZ.AX
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EZZ.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EZZ.AX
View MoreValuation Measures
Market Cap
68.87M
Enterprise Value
49.46M
Trailing P/E
7.10
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.86
Price/Book (mrq)
2.87
Enterprise Value/Revenue
0.66
Enterprise Value/EBITDA
3.62
Financial Highlights
Profitability and Income Statement
Profit Margin
12.02%
Return on Assets (ttm)
31.95%
Return on Equity (ttm)
45.86%
Revenue (ttm)
75.03M
Net Income Avi to Common (ttm)
9.02M
Diluted EPS (ttm)
0.2100
Balance Sheet and Cash Flow
Total Cash (mrq)
19.89M
Total Debt/Equity (mrq)
1.99%
Levered Free Cash Flow (ttm)
7.08M